COMMUNIQUÉS West-GlobeNewswire

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting
15/04/2025
New clinical data from the SYMON-I study to evaluate IL-6 in sepsis patients to be presented. ACTON, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced acceptance of an [...]
Remix Therapeutics Appoints Linda C. Bain to Board of Directors
15/04/2025
WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers [...]
Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model
15/04/2025
Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity model New in vitro data demonstrates superior potency of [...]
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares
15/04/2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES A&R PROSPECTUS AND FINAL PROSPECTUS ACCESSIBLE ON SEDAR+ TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. ( [...]
Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit
15/04/2025
HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology [...]
Native Path Native Hydrate Reviews [Urgent Update]: Don’t Buy Until You Read This
15/04/2025
Native Hydrate by Native Path Reviews Woodhaven, N.Y., April 15, 2025 (GLOBE NEWSWIRE) -- What if the key to better hydration and muscle recovery wasn’t in sugary sports drinks but in a clean, science-backed formula? [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
15/04/2025
Company Announcement Net sales of DARZALEX ® in the first quarter of 2025 totaled USD 3,237 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc [...]
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
15/04/2025
LONDON and RALEIGH, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the first quarter ended March 31, [...]
Best Diabetes Supplement of 2025: Learn How GlucoRedi Sets a New Benchmark in Wellness Industry
15/04/2025
Nampa, April 15, 2025 (GLOBE NEWSWIRE) -- Best Diabetes Supplement of 2025: Learn How GlucoRedi Sets a New Benchmark in Wellness Industry Glucoredi diabetes supplement Content Promoted By Branding EX Solution pvt ltd ( [...]
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
15/04/2025
MILAN and NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Pierluigi Paracchi , CEO Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, will present at “Montalcini Global [...]
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
15/04/2025
Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announced the second closing and completion of a [...]
How to Lower Blood Sugar Naturally: A Comprehensive Review of GlucoRedi, the Best Diabetes Supplement
15/04/2025
Nampa, April 15, 2025 (GLOBE NEWSWIRE) -- How to Lower Blood Sugar Naturally: A Comprehensive Review of GlucoRedi, the Best Diabetes Supplement Glucoredi diabetes control supplement Content promoted through the Branding [...]
Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities
15/04/2025
- Appointments come as the business invests a six-figure sum into advanced technology and systems - CHAPEL-EN-LE-FRITH, United Kingdom, April 15, 2025 (GLOBE NEWSWIRE) -- Concept Life Sciences (CLS), a leading [...]
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
15/04/2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro- [...]
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
15/04/2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro- [...]
Statutory negotiations at Orion's R&D unit in Turku, Finland have been concluded
15/04/2025
ORION CORPORATION PRESS RELEASE 15 April 2025 at 10.00 EEST Statutory negotiations at Orion's R&D unit in Turku, Finland have been concluded Orion Corporation announced in a press release on 10 March 2025 that the [...]
Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
15/04/2025
MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeutics Cyprumed will be eligible to receive up to $493 million in upfront, development, regulatory and sales [...]
Correction: Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S
15/04/2025
April 15, 2025 Announcement no. 11 Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S Copenhagen, Denmark, April 15, 2025, (GLOBE NEWSWIRE) – BioPorto A/S [...]
Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S
15/04/2025
April 15, 2025 Announcement no. 11 Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S Copenhagen, Denmark, April 15, 2025, (GLOBE NEWSWIRE) – BioPorto A/S [...]

Pages